407 related articles for article (PubMed ID: 8524852)
1. Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky AB; Zechiedrich EL; Cozzarelli NR
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11801-5. PubMed ID: 8524852
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.
Khodursky AB; Cozzarelli NR
J Biol Chem; 1998 Oct; 273(42):27668-77. PubMed ID: 9765303
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
Zechiedrich EL; Khodursky AB; Cozzarelli NR
Genes Dev; 1997 Oct; 11(19):2580-92. PubMed ID: 9334322
[TBL] [Abstract][Full Text] [Related]
4. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
5. Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli.
Zechiedrich EL; Cozzarelli NR
Genes Dev; 1995 Nov; 9(22):2859-69. PubMed ID: 7590259
[TBL] [Abstract][Full Text] [Related]
6. Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays.
Khodursky AB; Peter BJ; Schmid MB; DeRisi J; Botstein D; Brown PO; Cozzarelli NR
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9419-24. PubMed ID: 10944214
[TBL] [Abstract][Full Text] [Related]
7. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
Hsu YH; Chung MW; Li TK
Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
[TBL] [Abstract][Full Text] [Related]
8. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
Strahilevitz J; Hooper DC
Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
[TBL] [Abstract][Full Text] [Related]
9. Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA.
Aedo S; Tse-Dinh YC
Antimicrob Agents Chemother; 2012 Nov; 56(11):5458-64. PubMed ID: 22869559
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates.
Ostrer L; Khodursky RF; Johnson JR; Hiasa H; Khodursky A
Int J Antimicrob Agents; 2019 Mar; 53(3):318-324. PubMed ID: 30582984
[TBL] [Abstract][Full Text] [Related]
11. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
Hardy CD; Cozzarelli NR
Antimicrob Agents Chemother; 2003 Mar; 47(3):941-7. PubMed ID: 12604525
[TBL] [Abstract][Full Text] [Related]
12. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Bansal S; Tandon V
Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
[TBL] [Abstract][Full Text] [Related]
13. Contrasting enzymatic activities of topoisomerase IV and DNA gyrase from Escherichia coli.
Ullsperger C; Cozzarelli NR
J Biol Chem; 1996 Dec; 271(49):31549-55. PubMed ID: 8940171
[TBL] [Abstract][Full Text] [Related]
14. Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV.
Pan XS; Gould KA; Fisher LM
Antimicrob Agents Chemother; 2009 Sep; 53(9):3822-31. PubMed ID: 19564360
[TBL] [Abstract][Full Text] [Related]
15. DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica K; Zhao X
Microbiol Mol Biol Rev; 1997 Sep; 61(3):377-92. PubMed ID: 9293187
[TBL] [Abstract][Full Text] [Related]
16. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.
Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of and resistance to ciprofloxacin.
Hooper DC; Wolfson JS; Ng EY; Swartz MN
Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of plasmid-mediated quinolone resistance.
Tran JH; Jacoby GA
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5638-42. PubMed ID: 11943863
[TBL] [Abstract][Full Text] [Related]
19. [Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
González-Soltero R; García-Cañas A; Mohedano RB; Mendoza-Chamizo B; Botello E
Rev Esp Quimioter; 2015 Jun; 28(3):139-44. PubMed ID: 26032998
[TBL] [Abstract][Full Text] [Related]
20. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
Deguchi T; Kikuchi M; Yasuda M; Ito S
J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
